Cited by 12Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology ResearchNeuroinflammation and Neurodegeneration Mechanisms

Aberrant synaptic PTEN in symptomatic Alzheimer's patients may link synaptic depression to network failure

Open access
Díaz González, Marta, Buberman, Assaf, Morales, Miguel, Ferrer, Isidro, Knafo, Shira·2021·Frontiers in Synaptic Neuroscience

Abstract

In Alzheimer's disease (AD), Amyloid β (Aβ) impairs synaptic function by inhibiting long-term potentiation (LTP), and by facilitating long-term depression (LTD). There is now evidence from AD models that Aβ provokes this shift toward synaptic depression by triggering the access to and accumulation of PTEN in the postsynaptic terminal of hippocampal neurons. Here we quantified the PTEN in 196,138 individual excitatory dentate gyrus synapses from AD patients at different stages of the disease and from controls with no neuropathological findings. We detected a gradual increase of synaptic PTEN in AD brains as the disease progresses, in conjunction with a significant decrease in synaptic density. The synapses that remain in symptomatic AD patients are more likely to be smaller and exhibit fewer AMPA receptors (AMPARs). Hence, a high Aβ load appears to strongly compromise human hippocampal synapses, as reflected by an increase in PTEN, inducing a loss of AMPARs that may eventually provoke synaptic failure and loss.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnsyn.2021.683290

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the AD brain, Aβ recruits PTEN protein into neuronal synapses, which drives synaptic depression.

    “In the AD brain, Aβ recruits PTEN protein into neuronal synapses, which drives synaptic depression. 62”

    From Disruption of hippocampal upstream regulators of mTOR and insulin pathways in Down syndrome with Alzheimer's disease neuropathology: Preliminary observations (2026) · cites this paper as [62]

    The Discussion (page not supplied) describes Aβ-driven PTEN recruitment and synaptic depression as a proposed mechanism supported by cellular AD models. In human AD brains, the paper finds increased synaptic PTEN associated with synaptic changes, but does not establish that Aβ causes PTEN recruitment or that PTEN drives depression there. The claim states that causal sequence in the AD brain more firmly than the source does. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Díaz González, M., Buberman, A., Morales, M., Ferrer, I., & Knafo, S.
Affiliations
  • Ben-Gurion University of the Negev (IL)
  • University of the Basque Country (ES)
  • Ikerbasque (ES)
Corresponding author
Knafo, Shira
Venue
Frontiers in Synaptic Neuroscience
Published
2021-05-11
Volume
13
Pages
683290-683290
ISSN
1663-3563 (ISSN-L)
OpenAlex
W3162156382
Cited by
12
References
49
Citations by year
2026: 4 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 2
FWCI
0.79
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Synaptic Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Communities in ADDI (Universidad del Pais Vasco) (submittedVersion, cc-by)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Hispana (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, PTEN, amyloid-beta, synaptic depression, long-term depression, long-term potentiation, AMPA receptors, hippocampus, dentate gyrus, synaptic density, synaptic failure, synaptic loss, disease progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review